418 related articles for article (PubMed ID: 26577755)
1. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
Broecker J; Jurich J; Fuchs R
Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
[TBL] [Abstract][Full Text] [Related]
2. Long-Acting Reversible Contraceptive Uptake before and after the Affordable Care Act Contraceptive Mandate in Women Undergoing First Trimester Surgical Abortion.
Bell KN; Meyn LA; Chen BA
Womens Health Issues; 2018; 28(4):301-305. PubMed ID: 29853173
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
5. Changes in out-of-pocket payments for contraception by privately insured women during implementation of the federal contraceptive coverage requirement.
Finer LB; Sonfield A; Jones RK
Contraception; 2014 Feb; 89(2):97-102. PubMed ID: 24332745
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Mavranezouli I;
Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
[TBL] [Abstract][Full Text] [Related]
7. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
8. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
9. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
11. Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods.
Pace LE; Dusetzina SB; Keating NL
Med Care; 2016 Sep; 54(9):811-7. PubMed ID: 27213549
[TBL] [Abstract][Full Text] [Related]
12. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
Harney C; Dude A; Haider S
Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
[TBL] [Abstract][Full Text] [Related]
14. The Impact of the Affordable Care Act on Contraceptive Use and Costs among Privately Insured Women.
Snyder AH; Weisman CS; Liu G; Leslie D; Chuang CH
Womens Health Issues; 2018; 28(3):219-223. PubMed ID: 29544988
[TBL] [Abstract][Full Text] [Related]
15. Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.
Moniz MH; Soliman AB; Kolenic GE; Tilea A; Fendrick AM; Bell S; Dalton VK
Womens Health Issues; 2019; 29(6):465-470. PubMed ID: 31495642
[TBL] [Abstract][Full Text] [Related]
16. Long acting reversible contraception in adolescents with cardiovascular conditions.
Amies Oelschlager AM; Micks EA; Debiec KE; Nizamic T; Mantrala MD; Prager SW
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):353-5. PubMed ID: 25256877
[TBL] [Abstract][Full Text] [Related]
17. Achieving cost-neutrality with long-acting reversible contraceptive methods.
Trussell J; Hassan F; Lowin J; Law A; Filonenko A
Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
[TBL] [Abstract][Full Text] [Related]
18. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
Pickle S; Wu J; Burbank-Schmitt E
Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
[TBL] [Abstract][Full Text] [Related]
19. The impact of out-of-pocket costs on the use of intrauterine contraception among women with employer-sponsored insurance.
Pace LE; Dusetzina SB; Fendrick AM; Keating NL; Dalton VK
Med Care; 2013 Nov; 51(11):959-63. PubMed ID: 24036995
[TBL] [Abstract][Full Text] [Related]
20. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
